175 related articles for article (PubMed ID: 35842463)
1. SIRT4 functions as a tumor suppressor during prostate cancer by inducing apoptosis and inhibiting glutamine metabolism.
Cai G; Ge Z; Xu Y; Cai L; Sun P; Huang G
Sci Rep; 2022 Jul; 12(1):12208. PubMed ID: 35842463
[TBL] [Abstract][Full Text] [Related]
2. SIRT4 inhibits the proliferation, migration, and invasion abilities of thyroid cancer cells by inhibiting glutamine metabolism.
Chen Z; Lin J; Feng S; Chen X; Huang H; Wang C; Yu Y; He Y; Han S; Zheng L; Huang G
Onco Targets Ther; 2019; 12():2397-2408. PubMed ID: 30992675
[TBL] [Abstract][Full Text] [Related]
3. Loss of SIRT4 promotes the self-renewal of Breast Cancer Stem Cells.
Du L; Liu X; Ren Y; Li J; Li P; Jiao Q; Meng P; Wang F; Wang Y; Wang YS; Wang C
Theranostics; 2020; 10(21):9458-9476. PubMed ID: 32863939
[No Abstract] [Full Text] [Related]
4. Tumour-suppressive function of SIRT4 in human colorectal cancer.
Miyo M; Yamamoto H; Konno M; Colvin H; Nishida N; Koseki J; Kawamoto K; Ogawa H; Hamabe A; Uemura M; Nishimura J; Hata T; Takemasa I; Mizushima T; Doki Y; Mori M; Ishii H
Br J Cancer; 2015 Jul; 113(3):492-9. PubMed ID: 26086877
[TBL] [Abstract][Full Text] [Related]
5. SIRT4 protein suppresses tumor formation in genetic models of Myc-induced B cell lymphoma.
Jeong SM; Lee A; Lee J; Haigis MC
J Biol Chem; 2014 Feb; 289(7):4135-44. PubMed ID: 24368766
[TBL] [Abstract][Full Text] [Related]
6. Clinical and therapeutic significance of sirtuin-4 expression in colorectal cancer.
Huang G; Cheng J; Yu F; Liu X; Yuan C; Liu C; Chen X; Peng Z
Oncol Rep; 2016 May; 35(5):2801-10. PubMed ID: 26986234
[TBL] [Abstract][Full Text] [Related]
7. Overexpression of SIRT4 inhibits the proliferation of gastric cancer cells through cell cycle arrest.
Hu Y; Lin J; Lin Y; Chen X; Zhu G; Huang G
Oncol Lett; 2019 Feb; 17(2):2171-2176. PubMed ID: 30745932
[TBL] [Abstract][Full Text] [Related]
8. Sirtuin 4 Depletion Promotes Hepatocellular Carcinoma Tumorigenesis Through Regulating Adenosine-Monophosphate-Activated Protein Kinase Alpha/Mammalian Target of Rapamycin Axis in Mice.
Wang YS; Du L; Liang X; Meng P; Bi L; Wang YL; Wang C; Tang B
Hepatology; 2019 Apr; 69(4):1614-1631. PubMed ID: 30552782
[TBL] [Abstract][Full Text] [Related]
9. Mammalian SIRT4 is a tumor suppressor of clear cell renal cell carcinoma by inhibiting cancer proliferation, migration and invasion.
Wang C; Piao C; Liu J; Zhang Z; Zhu Y; Kong C
Cancer Biomark; 2020; 29(4):453-462. PubMed ID: 32675395
[TBL] [Abstract][Full Text] [Related]
10. Mitochondrial PAK6 inhibits prostate cancer cell apoptosis
Li T; Li Y; Liu T; Hu B; Li J; Liu C; Liu T; Li F
Theranostics; 2020; 10(6):2571-2586. PubMed ID: 32194820
[No Abstract] [Full Text] [Related]
11. Anabolic SIRT4 Exerts Retrograde Control over TORC1 Signaling by Glutamine Sparing in the Mitochondria.
Shaw E; Talwadekar M; Rashida Z; Mohan N; Acharya A; Khatri S; Laxman S; Kolthur-Seetharam U
Mol Cell Biol; 2020 Jan; 40(2):. PubMed ID: 31685549
[TBL] [Abstract][Full Text] [Related]
12. The PIK3CA-E545K-SIRT4 signaling axis reduces radiosensitivity by promoting glutamine metabolism in cervical cancer.
Jiang W; Ouyang X; Ji Z; Shi W; Wu Y; Yao Q; Wang Y; Yang W; Xiang L; Yang H
Cancer Lett; 2023 Mar; 556():216064. PubMed ID: 36646410
[TBL] [Abstract][Full Text] [Related]
13. SIRT4 has tumor-suppressive activity and regulates the cellular metabolic response to DNA damage by inhibiting mitochondrial glutamine metabolism.
Jeong SM; Xiao C; Finley LW; Lahusen T; Souza AL; Pierce K; Li YH; Wang X; Laurent G; German NJ; Xu X; Li C; Wang RH; Lee J; Csibi A; Cerione R; Blenis J; Clish CB; Kimmelman A; Deng CX; Haigis MC
Cancer Cell; 2013 Apr; 23(4):450-63. PubMed ID: 23562301
[TBL] [Abstract][Full Text] [Related]
14. SIRT4 is an independent prognostic factor in bladder cancer and inhibits bladder cancer growth by suppressing autophagy.
Yin J; Cai G; Wang H; Chen W; Liu S; Huang G
Cell Div; 2023 Jun; 18(1):9. PubMed ID: 37301821
[TBL] [Abstract][Full Text] [Related]
15. Sirtuin-4 (SIRT4) is downregulated and associated with some clinicopathological features in gastric adenocarcinoma.
Huang G; Cui F; Yu F; Lu H; Zhang M; Tang H; Peng Z
Biomed Pharmacother; 2015 May; 72():135-9. PubMed ID: 26054687
[TBL] [Abstract][Full Text] [Related]
16. Decreased SIRT4 protein levels in endometrioid adenocarcinoma tissues are associated with advanced AJCC stage.
Chen X; Lai X; Wu C; Tian Q; Lei T; Pan J; Huang G
Cancer Biomark; 2017 Jul; 19(4):419-424. PubMed ID: 28582846
[TBL] [Abstract][Full Text] [Related]
17. CtBP maintains cancer cell growth and metabolic homeostasis via regulating SIRT4.
Wang L; Zhou H; Wang Y; Cui G; Di LJ
Cell Death Dis; 2015 Jan; 6(1):e1620. PubMed ID: 25633289
[TBL] [Abstract][Full Text] [Related]
18. SIRT4 inhibits malignancy progression of NSCLCs, through mitochondrial dynamics mediated by the ERK-Drp1 pathway.
Fu L; Dong Q; He J; Wang X; Xing J; Wang E; Qiu X; Li Q
Oncogene; 2017 May; 36(19):2724-2736. PubMed ID: 27941873
[TBL] [Abstract][Full Text] [Related]
19. SIRT4 is the molecular switch mediating cellular proliferation in colorectal cancer through GLS mediated activation of AKT/GSK3β/CyclinD1 pathway.
Cui Y; Bai Y; Yang J; Yao Y; Zhang C; Liu C; Shi J; Li Q; Zhang J; Lu X; Zhang Y
Carcinogenesis; 2021 Apr; 42(3):481-492. PubMed ID: 33315089
[TBL] [Abstract][Full Text] [Related]
20. Downregulation of SIRT4 Expression Is Associated with Poor Prognosis in Esophageal Squamous Cell Carcinoma.
Nakahara Y; Yamasaki M; Sawada G; Miyazaki Y; Makino T; Takahashi T; Kurokawa Y; Nakajima K; Takiguchi S; Mimori K; Mori M; Doki Y
Oncology; 2016; 90(6):347-55. PubMed ID: 27082627
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
